Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease

BACKGROUND: Pediatric patients with advanced chronic kidney disease (CKD) are often prescribed oral phosphate binders (PBs) for the management of hyperphosphatemia. However, available PBs have limitations, including unfavorable tolerability and safety. METHODS: This phase 3, multicenter, randomized,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatr Nephrol
Hlavní autoři: Greenbaum, Larry A., Jeck, Nikola, Klaus, Günter, Fila, Marc, Stoica, Cristina, Fathallah-Shaykh, Sahar, Paredes, Ana, Wickman, Larysa, Nelson, Raoul, Swinford, Rita D., Abitbol, Carolyn Larkins, Balgradean, Mihaela, Jankauskiene, Augustina, Perrin, Amandine, Enoiu, Milica, Ahn, Sun-Young
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009783/
https://ncbi.nlm.nih.gov/pubmed/33106892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-020-04805-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky